These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31990955)

  • 1. Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines.
    Mora-Lagos B; Cartas-Espinel I; Riquelme I; Parker AC; Piccolo SR; Viscarra T; Reyes ME; Zanella L; Buchegger K; Ili C; Brebi P
    PLoS One; 2020; 15(1):e0228331. PubMed ID: 31990955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
    Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
    Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
    Xi Z; Si J; Nan J
    Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-Generation Sequencing Analysis of mRNA Profile in Cisplatin-Resistant Gastric Cancer Cell Line SGC7901.
    Deng Z; Wang H; Guo G; Li X; Cai Y; Tang Y; Wang Y; Li J; Lu Z; Yu X; Li R; Li L
    Med Sci Monit; 2019 Apr; 25():2386-2396. PubMed ID: 30938333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
    Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
    Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of FAM3B Promotes Cisplatin Resistance in Gastric Cancer by Inducing Epithelial-Mesenchymal Transition.
    Song C; Duan C
    Med Sci Monit; 2020 May; 26():e921002. PubMed ID: 32442162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KLF5-mediated aquaporin 3 activated autophagy to facilitate cisplatin resistance of gastric cancer.
    Dai X; Chen Y; Chen N; Dou J; Zhuang H; Wang J; Zhao X; Zhang X; Zhao H
    Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):140-152. PubMed ID: 36083020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
    Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
    Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells.
    Tanaka M; Kataoka H; Yano S; Ohi H; Kawamoto K; Shibahara T; Mizoshita T; Mori Y; Tanida S; Kamiya T; Joh T
    BMC Cancer; 2013 May; 13():237. PubMed ID: 23672493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells.
    Rodrigo MAM; Buchtelova H; Jimenez AMJ; Adam P; Babula P; Heger Z; Adam V
    Cells; 2019 Mar; 8(3):. PubMed ID: 30871063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
    Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
    Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618/BCL2 axis.
    Zhang Q; Miao Y; Fu Q; Hu H; Chen H; Zeng A; Jin Y; Jiang Y; Qian L; Wu L; Xu L; Wang G; Qiu L; Huang X; Xia Y
    Biochem Biophys Res Commun; 2020 Jun; 526(3):713-720. PubMed ID: 32253030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
    Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
    Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid-mediated miR-30a up-regulation suppresses autophagy and sensitizes gastric cancer cells to cisplatin.
    Abbasi A; Hosseinpourfeizi M; Safaralizadeh R
    Life Sci; 2022 Oct; 307():120884. PubMed ID: 35973456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Metastasis-Related Genes in Cisplatin Chemoresistance in Gastric Cancer.
    Nishiguchi Y; Oue N; Fujiwara-Tani R; Sasaki T; Ohmori H; Kishi S; Mori S; Mori T; Ikeda N; Matsumoto S; Wakatsuki K; Luo Y; Yasui W; Sho M; Kuniyasu H
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
    Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
    Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2.
    Li H; Ma X; Yang D; Suo Z; Dai R; Liu C
    J Cell Biochem; 2020 Feb; 121(2):1353-1361. PubMed ID: 31478258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization of cisplatin-resistance in MKN-45 human stomach adenocarcinoma cell line.
    Hong WS; Son YS
    Anticancer Res; 1996; 16(5A):3031-6. PubMed ID: 8917423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.